Cargando…

Effect of age, sex, and morbidity count on trial attrition: meta-analysis of individual participant level data from phase 3/4 industry funded clinical trials

OBJECTIVES: To estimate the association between individual participant characteristics and attrition from randomised controlled trials. DESIGN: Meta-analysis of individual participant level data (IPD). DATA SOURCES: Clinical trial repositories (Clinical Study Data Request and Yale University Open Da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lees, Jennifer S, Hanlon, Peter, Butterly, Elaine W, Wild, Sarah H, Mair, Frances S, Taylor, Rod S, Guthrie, Bruce, Gillies, Katie, Dias, Sofia, Welton, Nicky J, McAllister, David A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978693/ https://www.ncbi.nlm.nih.gov/pubmed/36936559 http://dx.doi.org/10.1136/bmjmed-2022-000217

Ejemplares similares

Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data
por: Hanlon, Peter, et al.
Publicado: (2022)

Treatment effect modification due to comorbidity: Individual participant data meta-analyses of 120 randomised controlled trials
por: Hanlon, Peter, et al.
Publicado: (2023)

Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventions
por: Hanlon, Peter, et al.
Publicado: (2020)

Comorbidity and health-related quality of life in people with a chronic medical condition in randomised clinical trials: An individual participant data meta-analysis
por: Butterly, Elaine W., et al.
Publicado: (2023)

Correlations between comorbidities in trials and the community: An individual-level participant data meta-analysis
por: Crowther, Jamie, et al.
Publicado: (2023)

Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis
por: Hanlon, Peter, et al.
Publicado: (2019)

Frailty in randomised controlled trials for dementia or mild cognitive impairment measured via the frailty index: prevalence and prediction of serious adverse events and attrition
por: Wightman, Heather, et al.
Publicado: (2023)

Improving the Estimation of Subgroup Effects for Clinical Trial Participants with Multimorbidity by Incorporating Drug Class-Level Information in Bayesian Hierarchical Models: A Simulation Study
por: Hannigan, Laurie J., et al.
Publicado: (2021)

Frailty measurement, prevalence, incidence, and clinical implications in people with diabetes: a systematic review and study-level meta-analysis
por: Hanlon, Peter, et al.
Publicado: (2020)

Identification and prevalence of frailty in diabetes mellitus and association with clinical outcomes: a systematic review protocol
por: Hanlon, Peter, et al.
Publicado: (2020)

An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes
por: Hanlon, Peter, et al.
Publicado: (2021)

Observed and expected serious adverse event rates in randomised clinical trials for hypertension: an observational study comparing trials that do and do not focus on older people
por: Hanlon, Peter, et al.
Publicado: (2021)

Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol
por: Butterly, Elaine, et al.
Publicado: (2022)

Are pilot trials useful for predicting randomisation and attrition rates in definitive studies: A review of publicly funded trials
por: Cooper, Cindy L, et al.
Publicado: (2018)

Strategies to reduce attrition in randomised trials
por: Brueton, Valerie, et al.
Publicado: (2011)

Prevalence, measurement, and implications of frailty in stroke survivors: An analysis of three global aging cohorts
por: Hanlon, Peter, et al.
Publicado: (2023)

Systematic review and meta-analysis of prevalence, trajectories, and clinical outcomes for frailty in COPD
por: Hanlon, Peter, et al.
Publicado: (2023)

Counting the cost of public and philanthropic R&D funding: the case of olaparib
por: Schmidt, L., et al.
Publicado: (2022)

Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies
por: Hanlon, Peter, et al.
Publicado: (2022)

How do trial teams plan for retention during the design stage of the trial? A scoping review
por: Murphy, Ellen, et al.
Publicado: (2023)

Information about dissemination of trial results in patient information leaflets for clinicals trials in the UK and Ireland: The what and the when
por: Bjorklund, Matilda, et al.
Publicado: (2022)

How do trial teams plan for retention during the design stage of the trial? A scoping review protocol
por: Murphy, Ellen, et al.
Publicado: (2022)

Impact of Length or Relevance of Questionnaires on Attrition in Online Trials: Randomized Controlled Trial
por: McCambridge, Jim, et al.
Publicado: (2011)

Frailty in people with rheumatoid arthritis: a systematic review of observational studies
por: Hanlon, Peter, et al.
Publicado: (2022)

Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2018)

Impact and Costs of Incentives to Reduce Attrition in Online Trials: Two Randomized Controlled Trials
por: Khadjesari, Zarnie, et al.
Publicado: (2011)

Frailty in rheumatoid arthritis and its relationship with disease activity, hospitalisation and mortality: a longitudinal analysis of the Scottish Early Rheumatoid Arthritis cohort and UK Biobank
por: Hanlon, Peter, et al.
Publicado: (2022)

Frailty in COPD: an analysis of prevalence and clinical impact using UK Biobank
por: Hanlon, Peter, et al.
Publicado: (2022)

Attrition Revisited: Adherence and Retention in a Web-Based Alcohol Trial
por: Murray, Elizabeth, et al.
Publicado: (2013)

Self-management interventions for Type 2 Diabetes: systematic review protocol focusing on patient workload and capacity support
por: Hanlon, Peter, et al.
Publicado: (2021)

Constructing Relative Effect Priors for Research Prioritization and Trial Design: A Meta-epidemiological Analysis
por: Glynn, David, et al.
Publicado: (2023)

The Law of Attrition
por: Eysenbach, Gunther
Publicado: (2005)

Counting Calabi-Yau Threefolds
por: Gendler, Naomi, et al.
Publicado: (2023)

Potential impact of NICE guidelines on referrals from primary care to nephrology: a primary care database and prospective research study
por: Sullivan, Michael K, et al.
Publicado: (2022)

Attrition in longitudinal randomized controlled trials: home visits make a difference
por: Peterson, Janey C, et al.
Publicado: (2012)

Attrition of Patients on a Precision Oncology Trial: Analysis of the I‐PREDICT Experience
por: Bohan, Sandy S., et al.
Publicado: (2020)

Insights from pre-treatment attrition & dropouts in an effectiveness trial of methylphenidate in children
por: Shah, Ruchita, et al.
Publicado: (2020)

Predicting attrition of men with a history of violence from randomised clinical trials
por: Doring, Natalie, et al.
Publicado: (2023)

Protocol for Correcting Residual Errors with Spectral, ULtrasound, Traditional Speech therapy Randomized Controlled Trial (C-RESULTS RCT)
por: McAllister, Tara, et al.
Publicado: (2020)

Development of a method for adjusting trial results for biases in meta-analysis
por: Turner, Rebecca, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ltfvh2ik611im8o4oa2797hieg